Literature DB >> 6431978

Activation of prostacyclin synthesis in cultured aortic smooth muscle cells by 'diuretic-antihypertensive' drugs.

B Dorian, J Larrue, F V Defeudis, H Salari, P Borgeat, P Braquet.   

Abstract

In cultured smooth muscle cells of rat aorta, four diuretic agents, furosemide, bumetanide, cicletanide and piretanide (all at 10(-6)-10(-5) M), significantly enhanced the transformation of exogenously added arachidonic acid (AA) to prostacyclin. Studies with cultured smooth muscle cells and human leukocytes revealed that these same agents failed to inhibit lipoxygenase pathways. Taken together, these results indicate that the diuretic properties of these agents might be associated with a general activation of the AA cascade.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431978     DOI: 10.1016/0006-2952(84)90665-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Acute effects of cicletanine in angina pectoris.

Authors:  D L Murdoch; E Henderson; H J Dargie; G T McInnes
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

2.  Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids.

Authors:  N Ferry; J Geoffroy; N Pozet; G Cuisinaud; D Benzoni; P Y Zech; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

3.  A comparison of the acute effects of cicletanine and bendrofluazide on urinary electrolytes and plasma potassium in essential hypertension.

Authors:  D R Singer; N D Markandu; A L Sugden; G A MacGregor
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Activators of potassium channels enhance calcium influx into endothelial cells as a consequence of potassium currents.

Authors:  A Lückhoff; R Busse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

Review 5.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

6.  Comparison of in vitro effects of cicletanine, its enantiomers and major metabolite on rat thoracic aorta.

Authors:  E O Mikkelsen; J Sehested; S H Poulsen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

7.  Effects of cicletanine on haemodynamics, arrhythmias and extent of necrosis during coronary ligation in rabbits.

Authors:  T Burton; S Chakrabarty; D S Fluck; N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

8.  Stereoselective renal effects of the loop diuretic ozolinone in the anesthetized dog.

Authors:  M Barthelmebs; D Stephan; J P Krieger; M Grima; J L Imbs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.